Invesco
CRBU icon

Invesco’s Caribou Biosciences CRBU Stock Holding History

Invesco’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
83,502
+48,439
+138% +$83.1K ﹤0.01% 3544
2025
Q4 		$55.8K Buy
35,063
+22,856
+187% +$48K ﹤0.01% 3696
2025
Q3 		$28.4K Sell
12,207
-12,532
-51% -$23.7K ﹤0.01% 3769
2025
Q2 		$31.2K Sell
24,739
-34,235
-58% -$33.7K ﹤0.01% 3747
2025
Q1 		$53.8K Sell
58,974
-6,721
-10% -$8.73K ﹤0.01% 3689
2024
Q4 		$104K Sell
65,695
-391
-0.6% -$786 ﹤0.01% 3618
2024
Q3 		$130K Sell
66,086
-1,114
-2% -$2.28K ﹤0.01% 3584
2024
Q2 		$110K Sell
67,200
-3,062
-4% -$9.79K ﹤0.01% 3739
2024
Q1 		$361K Sell
70,262
-6,767
-9% -$41.7K ﹤0.01% 3464
2023
Q4 		$441K Buy
77,029
+8,665
+13% +$42.8K ﹤0.01% 3289
2023
Q3 		$327K Buy
68,364
+2,418
+4% +$15K ﹤0.01% 3415
2023
Q2 		$280K Sell
65,946
-3,517
-5% -$15.8K ﹤0.01% 3514
2023
Q1 		$369K Buy
69,463
+47,922
+222% +$298K ﹤0.01% 3430
2022
Q4 		$135K Sell
21,541
-293,511
-93% -$2.61M ﹤0.01% 3775
2022
Q3 		$3.32M Buy
315,052
+296,643
+1,611% +$2.76M ﹤0.01% 2417
2022
Q2 		$100K Buy
18,409
+6,296
+52% +$48.1K ﹤0.01% 3887
2022
Q1 		$110K Buy
+12,113
New +$128K ﹤0.01% 3861

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco's CRBU Position: Q1 2026 in Review

Invesco increased its Caribou Biosciences (CRBU) stake by 138% in Q1 2026, buying an estimated $83.1K and bringing the position to 83,502 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #3544.

Invesco first reported a position in CRBU in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.32M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Invesco held 83,502 shares of Caribou Biosciences worth $159K as of Q1 2026.
  • Invesco bought 48,439 Caribou Biosciences shares in Q1 2026, an estimated $83.1K.
  • Caribou Biosciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3544 holding.
  • Invesco first reported a position in Caribou Biosciences in Q1 2022 and has held it in 17 quarters since.
  • Invesco's Caribou Biosciences position peaked at $3.32M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.